on LR Health & Beauty SE (isin : NO0013149658)
LR Health & Beauty SE Achieves Sales Growth in Q4 2024
LR Health & Beauty SE reported a significant increase in sales in Q4 2024, resulting in meeting its annual forecast. The company saw an 8.0% sales growth in the final quarter, reaching EUR 76.5 million. Yearly sales rose by 4.6% to EUR 289.2 million, aligning with the forecasted range.
Key contributing factors include the realignment of the career plan and successful launches like the LR ZEITGARD Signature. Despite these successes, EBITDA faced challenges, dropping to EUR 8.3 million in Q4 due to one-off charges.
CEO Dr. Andreas Laabs highlighted the company's strategic direction, focusing on product innovation and community engagement for sustained growth. The firm aims to streamline operations and enhance product offerings in 2025.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all LR Health & Beauty SE news